Cargando…
Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer
Although circulating cell-free DNA (cfDNA) is a promising biomarker for the diagnosis and prognosis of various tumors, clinical correlation of cfDNA with gastric cancer has not been fully understood. To address this, we developed a highly sensitive cfDNA capture system by integrating polydopamine (P...
Autores principales: | Bu, Jiyoon, Lee, Tae Hee, Jeong, Woo-jin, Poellmann, Michael J., Mudd, Kara, Eun, Hyuk Soo, Liu, Elizabeth W., Hong, Seungpyo, Hyun, Sung Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710035/ https://www.ncbi.nlm.nih.gov/pubmed/33264292 http://dx.doi.org/10.1371/journal.pone.0242145 |
Ejemplares similares
-
Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022) -
Deep cfDNA fragment end profiling enables cancer detection
por: Zhitnyuk, Yulia V., et al.
Publicado: (2022) -
Tri‐modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell‐free DNA using machine learning algorithm
por: Bu, Jiyoon, et al.
Publicado: (2021) -
Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
por: Kim, Kyongchol, et al.
Publicado: (2014) -
Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)